![]() |
Dalian Bio-Chem Company Limited (603360.SS) Avaliação DCF |

Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Dalian BIO-CHEM Company Limited (603360.SS) Bundle
Descubra o verdadeiro valor da Dalian Bio-Chem Company Limited (603360SS) com nossa calculadora DCF avançada! Ajuste as principais suposições, explore vários cenários e examine como diferentes mudanças afetam a avaliação da Dalian Bio-Chem Company Limited (603360SS)-tudo convenientemente dentro de um modelo do Excel.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 749.5 | 1,006.3 | 1,256.7 | 1,065.7 | 1,311.7 | 1,369.3 | 1,429.5 | 1,492.3 | 1,557.8 | 1,626.3 |
Revenue Growth, % | 0 | 34.25 | 24.88 | -15.2 | 23.09 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
EBITDA | 311.4 | 356.2 | 537.4 | 455.1 | 490.7 | 547.2 | 571.3 | 596.4 | 622.6 | 649.9 |
EBITDA, % | 41.54 | 35.4 | 42.76 | 42.7 | 37.41 | 39.96 | 39.96 | 39.96 | 39.96 | 39.96 |
Depreciation | 43.2 | 48.9 | 71.4 | 64.0 | 69.7 | 75.7 | 79.0 | 82.5 | 86.1 | 89.9 |
Depreciation, % | 5.76 | 4.86 | 5.68 | 6.01 | 5.32 | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 |
EBIT | 268.2 | 307.3 | 466.0 | 391.0 | 421.0 | 471.6 | 492.3 | 513.9 | 536.5 | 560.0 |
EBIT, % | 35.78 | 30.54 | 37.08 | 36.69 | 32.09 | 34.44 | 34.44 | 34.44 | 34.44 | 34.44 |
Total Cash | 343.4 | 294.5 | 418.0 | 599.5 | 668.2 | 590.3 | 616.2 | 643.3 | 671.6 | 701.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 134.2 | 192.9 | 176.6 | 390.3 | 551.6 | 355.5 | 371.1 | 387.4 | 404.4 | 422.2 |
Account Receivables, % | 17.9 | 19.17 | 14.05 | 36.63 | 42.05 | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 |
Inventories | 106.1 | 186.7 | 181.0 | 206.9 | 902.4 | 370.6 | 386.9 | 403.9 | 421.6 | 440.2 |
Inventories, % | 14.16 | 18.56 | 14.41 | 19.42 | 68.79 | 27.07 | 27.07 | 27.07 | 27.07 | 27.07 |
Accounts Payable | 65.4 | 142.0 | 66.8 | 62.6 | 117.7 | 117.8 | 122.9 | 128.3 | 134.0 | 139.9 |
Accounts Payable, % | 8.72 | 14.11 | 5.31 | 5.88 | 8.97 | 8.6 | 8.6 | 8.6 | 8.6 | 8.6 |
Capital Expenditure | -109.2 | -191.6 | -134.3 | -67.4 | -74.9 | -154.3 | -161.0 | -168.1 | -175.5 | -183.2 |
Capital Expenditure, % | -14.57 | -19.04 | -10.69 | -6.32 | -5.71 | -11.27 | -11.27 | -11.27 | -11.27 | -11.27 |
Tax Rate, % | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 | 16.66 |
EBITAT | 228.5 | 263.6 | 406.5 | 332.8 | 350.8 | 402.4 | 420.1 | 438.5 | 457.8 | 477.9 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -12.5 | 58.3 | 290.4 | 85.8 | -455.9 | 1,051.7 | 311.3 | 325.0 | 339.3 | 354.2 |
WACC, % | 4.96 | 4.96 | 4.96 | 4.96 | 4.95 | 4.96 | 4.96 | 4.96 | 4.96 | 4.96 |
PV UFCF | ||||||||||
SUM PV UFCF | 2,123.4 | |||||||||
Long Term Growth Rate, % | 3.50 | |||||||||
Free cash flow (T + 1) | 367 | |||||||||
Terminal Value | 25,164 | |||||||||
Present Terminal Value | 19,757 | |||||||||
Enterprise Value | 21,881 | |||||||||
Net Debt | -136 | |||||||||
Equity Value | 22,016 | |||||||||
Diluted Shares Outstanding, MM | 508 | |||||||||
Equity Value Per Share | 43.36 |
Benefits You Will Receive
- Flexible Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios effortlessly.
- Real-Time Data: Pre-filled financial metrics from Dalian BIO-CHEM Company Limited (603360SS) to streamline your analysis.
- Instant DCF Outputs: The template automatically computes Net Present Value (NPV) and intrinsic value for you.
- Tailored and Professional Design: A sleek Excel model that conforms to your valuation requirements.
- Designed for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Customizable Forecast Inputs: Easily adjust essential metrics such as revenue growth, EBITDA percentage, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High-Precision Accuracy: Leverages Dalian BIO-CHEM's (603360SS) actual financial data for credible valuation results.
- Simplified Scenario Analysis: Effortlessly test various assumptions and analyze outcomes side by side.
- Efficiency-Boosting Tool: Skip the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the pre-formatted Excel file containing Dalian BIO-CHEM Company Limited’s (603360SS) financial data.
- Customize: Tailor your forecasts, including revenue growth rates, EBITDA percentages, and WACC.
- Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate multiple projections and instantly compare the results.
- Make Decisions: Utilize the valuation findings to inform your investment strategy.
Why Choose This Calculator for Dalian BIO-CHEM Company Limited (603360SS)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses into a single, comprehensive tool.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes intrinsic value and Net Present Value for Dalian BIO-CHEM Company Limited (603360SS).
- Preloaded Information: Access to historical and projected data provides reliable starting points for analysis.
- Expert-Level Quality: Perfect for financial analysts, investors, and business consultants focusing on Dalian BIO-CHEM Company Limited (603360SS).
Who Can Benefit from This Product?
- Investors: Evaluate Dalian BIO-CHEM Company's valuation before making stock trades.
- CFOs and Financial Analysts: Optimize valuation assessments and validate financial forecasts.
- Startup Founders: Gain insights into the valuation methods of established firms like Dalian BIO-CHEM (603360SS).
- Consultants: Provide clients with comprehensive valuation reports.
- Students and Educators: Utilize real market data to practice and teach valuation methodologies.
What the Template Contains
- Pre-Filled DCF Model: Dalian BIO-CHEM's financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Analyze Dalian BIO-CHEM's profitability, leverage, and operational efficiency.
- Editable Inputs: Adjust assumptions like growth, margins, and CAPEX to align with your scenarios.
- Financial Statements: Comprehensive annual and quarterly reports for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.